Scientists reprogram cancer cells with low doses of epigenetic drugs
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) ...
Cancer
Mar 22, 2012 |
5 / 5 (1) |
0
|
Molecule's role in cancer suggests new combination therapy
Researchers at the University of Illinois at Chicago College of Medicine have found that a molecule found at elevated levels in cancer cells seems to protect them from the "cell-suicide" that is usually triggered by chemotherapy ...
Cancer
Mar 01, 2012 |
5 / 5 (2) |
0
|
Complications of blood cancers make termination advisable at early stages of pregnancy
Lymphoma is the fourth most common cancer in pregnancy, affecting one in 6000 pregnancies. Non-Hodgkin lymphoma, acute leukaemia, and other blood cancers, while also rare, can also occur in pregnancy. The need for urgent ...
Obstetrics & gynaecology
Feb 09, 2012 |
not rated yet |
0
Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their childre
A large, retrospective study shows that children of childhood cancer survivors who received prior treatment involving radiation to testes or ovaries and/or chemotherapy with alkylating agents do not have an increased risk ...
Cancer
Dec 12, 2011 |
not rated yet |
0
Research predicts how cancers will respond to chemo, rewrites old theory of why chemo works
Challenging a half-century-old theory about why chemotherapy agents target cancer, scientists at Dana-Farber Cancer Institute have devised a test that can predict how effective the drugs will be by determining whether a patient's ...
Cancer
Oct 27, 2011 |
5 / 5 (6) |
0
|
Newly discovered reservoir of antibiotic resistance genes
Waters polluted by the ordure of pigs, poultry, or cattle represent a reservoir of antibiotic resistance genes, both known and potentially novel. These resistance genes can be spread among different bacterial species by bacteriophage, ...
Medical research
Oct 21, 2011 |
5 / 5 (1) |
0
Newly identified DNA repair defect linked to increased risk of leukemia relapse
A newly identified defect in a DNA repair system might leave some young leukemia patients less likely to benefit from a key chemotherapy drug, possibly putting them at greater risk of relapse. The problem was identified in ...
Medical research
Sep 26, 2011 |
not rated yet |
1
|
Gene therapy reduces HIV levels in small trials
(Medical Xpress) -- This weekend at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, Illinois, researchers from two different study groups, one on the east coast and one on the west coast, ...
HIV & AIDS
Sep 20, 2011 |
4.8 / 5 (4) |
0
|
Growing concern over drugs fed to animals
Drugs fed to animals to promote growth and prevent diseases may play a key role in the emergence of antibiotic resistant bacteria, microbiologists said Sunday.
Diseases, Conditions, Syndromes
Sep 19, 2011 |
not rated yet |
4
New agents show promise for treating aggressive breast cancers
Some of the most aggressive forms of breast cancer are more vulnerable to chemotherapy when it is combined with a new class of anti-cancer agent, researchers from the Walter and Eliza Hall Institute have shown.
Cancer
Jul 18, 2011 |
not rated yet |
0
|
Research provides insight into new drug resistance in hospital microbes
Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions. Hospital-acquired infections are often resistant to multiple antibiotics, leading to ...
Medical research
Jul 13, 2011 |
not rated yet |
0
Old is new again: Study determines dosing for 1950s drug now being used to treat drug-resistant infections
(Medical Xpress) -- An ongoing study led by a University of Pittsburgh researcher has established the first scientifically-based dosing guidelines for a more than 50-year-old drug that has re-emerged as the best, and often ...
Medications
Jul 04, 2011 |
3 / 5 (1) |
0
|
Breast cancer drug pushes colon cancer cells to their death
A new treatment for colon cancer that combines a chemotherapy agent approved to treat breast cancer and a cancer-fighting antibody is ready for clinical trials, according to Penn State College of Medicine researchers.
Cancer
Jun 08, 2011 |
5 / 5 (2) |
1
|
Blood proteins may identify vulnerability of pancreatic cancers to avastin
(Medical Xpress) -- Tiny tumor proteins circulating in blood may be used to identify which pancreatic cancer patients would benefit from the drug Avastin, researchers at Duke University Medical Center have found.
Cancer
Jun 07, 2011 |
not rated yet |
0
New type of MRSA in hospitalized patients probably of animal origin
A distinctly new type of methicillin resistant Staphylococcus aureus (MRSA) that is not detected by traditional genetic screening methods has been discovered in patients in Irish hospitals according to research to be pub ...
Diseases, Conditions, Syndromes
Jun 02, 2011 |
not rated yet |
0
|
